GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eone Diagnomics Genome Center Co Ltd (XKRX:245620) » Definitions » 3-Year EBITDA Growth Rate

Eone Diagnomics Genome Center Co (XKRX:245620) 3-Year EBITDA Growth Rate : -190.20% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Eone Diagnomics Genome Center Co 3-Year EBITDA Growth Rate?

Eone Diagnomics Genome Center Co's EBITDA per Share for the three months ended in Mar. 2024 was ₩14.45.

During the past 3 years, the average EBITDA Per Share Growth Rate was -190.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -30.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Eone Diagnomics Genome Center Co was 52.50% per year. The lowest was -190.20% per year. And the median was 2.05% per year.


Competitive Comparison of Eone Diagnomics Genome Center Co's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Eone Diagnomics Genome Center Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eone Diagnomics Genome Center Co's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eone Diagnomics Genome Center Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Eone Diagnomics Genome Center Co's 3-Year EBITDA Growth Rate falls into.



Eone Diagnomics Genome Center Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Eone Diagnomics Genome Center Co  (XKRX:245620) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Eone Diagnomics Genome Center Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Eone Diagnomics Genome Center Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Eone Diagnomics Genome Center Co (XKRX:245620) Business Description

Traded in Other Exchanges
N/A
Address
4th Floor, 291 Harmony-ro, Yeonsu-Gu, Incheon, KOR, 22014
Eeone Diagnomics Genome Center Co Ltd is engaged in developing and personalizing medicine based on Next Generation Sequencing technology and cutting edge genomics analysis. The company provides various personal genome sequencing and bioinformatics solutions to biomedical researchers, physicians and individuals seeking to understand the genetic influence of personal health and disease.

Eone Diagnomics Genome Center Co (XKRX:245620) Headlines

No Headlines